Antithrombotic Therapy in Patients With Atrial Fibrillation and Prior Stroke in GLORIA-AF Phase II (Global Registry on Long-term Oral Antithrombotic Treatment in Patients With Atrial Fibrillation, Phase II).
第一作者机构:[1]Univ Hosp Essen, Dept Neurol, Essen, Germany;[2]Leiden Univ, Dept Thrombosis & Hemostasis, Med Ctr, Leiden, Netherlands;[3]Mt Sinai Med Ctr, Cardiovasc Inst, New York, NY 10029 USA;[4]Clin & Maternidad Suizo Argentina, Arrythmia & Electrophysiol Serv, Buenos Aires, Argentina;[5]Beijing An Zhen Hosp, Cardiol Dept, Atrial Fibrillat Ctr, Beijing, Peoples R China;[6]Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA;[7]Boehringer Ingelheim GmbH & Co KG, Global Epidemiol, Ingelheim, Germany;[8]Boehringer Ingelheim GmbH & Co KG, Corp Div Cardiol, Ingelheim, Germany;[9]Boehringer Ingelheim Canada, Burlington, ON, Canada;[10]Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany;[11]Univ Birmingham, Dept Cardiol, Ctr Cardiovasc Sci, Birmingham, W Midlands, England;[12]Boehringer Ingelheim GmbH & Co KG, Dept Global Epidemiol, Ingelheim, Germany
推荐引用方式(GB/T 7714):
Diener Hans-Christoph,Huisman Menno V,Halperin Jonathan L.,et al.Antithrombotic Therapy in Patients With Atrial Fibrillation and Prior Stroke in GLORIA-AF Phase II (Global Registry on Long-term Oral Antithrombotic Treatment in Patients With Atrial Fibrillation, Phase II).[J].STROKE.2016,47:-.
APA:
Diener, Hans-Christoph,Huisman, Menno, V,Halperin, Jonathan L.,Dubner, Sergio J.,Ma, Chang S....&Bartels, Dorothee.(2016).Antithrombotic Therapy in Patients With Atrial Fibrillation and Prior Stroke in GLORIA-AF Phase II (Global Registry on Long-term Oral Antithrombotic Treatment in Patients With Atrial Fibrillation, Phase II)..STROKE,47,
MLA:
Diener, Hans-Christoph,et al."Antithrombotic Therapy in Patients With Atrial Fibrillation and Prior Stroke in GLORIA-AF Phase II (Global Registry on Long-term Oral Antithrombotic Treatment in Patients With Atrial Fibrillation, Phase II).".STROKE 47.(2016):-